Concomitant antihypertensive medication and outcome of patients with metastatic castration ‐resistant prostate cancer receiving enzalutamide or abiraterone acetate

ConclusionThe findings of this study suggest an association between the concomitant use of ACEIs and longer survival of mCRPC patients receiving ENZ or ABI therapy.

Source: Cancer Medicine - January 2, 2024 Category: Cancer & Oncology Authors: Ond řej Fiala, Petr Hošek, Hana Korunková, Milan Hora, Jiří Kolář, Ondřej Šorejs, Ondřej Topolčan, Jan Filipovský, Václav Liška, Matteo Santoni, Sebastiano Buti, Jindřich Fínek Tags: RESEARCH ARTICLE Source Type: research